Endios Bio
PrivateLast Round
Accelerator
May 15, 2025
Total Funding Raised
$50,000
Company Overview
Endios Bio is a biotechnology company developing breakthrough therapeutics for rare neurodegenerative diseases by targeting the PEG10 gene.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endios Bio Comparables
Compare Endios Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trace Neuroscience | 79% | |
| QurAlis | 74% | |
| Vico Therapeutics | 72% | |
Endios Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 15, 2025 | ||||
| Accelerator | Mar 19, 2025 |
Key People
Founding team and executive leadership
Endios Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Embark Deep Tech Startup Creator | Accelerator |
| NSF I-Corps Program | Accelerator |
| Innosphere Ventures | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2025
Innosphere Ventures participated in the Accelerator round.
- Mar 19, 2025
$50K raised from Embark Deep Tech and NSF I-Corps.
Endios Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Endios Bio's valuation, stock price, and market status.